Table 4.
Effect of obesity/overweight on T2DM according to quartiles of risk allelic scores
| Quartiles of risk alleles | T2DM (n = 130) | Control (n = 135) | ORa | 95% CI | P |
|---|---|---|---|---|---|
| All subject | |||||
| Obese | 82 | 62 | 2.075 | 1.263–3.407 | 0.004 |
| Non‐obese | 48 | 73 | |||
| Q1 (≤14) | |||||
| Obese | 28 | 33 | 2.158 | 1.002–4.647 | 0.049 |
| Non‐obese | 19 | 43 | |||
| Q2 (15, 16) | |||||
| Obese | 32 | 18 | 2.431 | 1.022–5.782 | 0.044 |
| Non‐obese | 16 | 22 | |||
| Q3 (17, 18) | |||||
| Obese | 18 | 10 | 0.667 | 0.150–2.973 | 0.595 |
| Non‐obese | 9 | 4 | |||
| Q4 (≥19) | |||||
| Obese | 4 | 1 | 4.978 | 0.306–81.083 | 0.26 |
| Non‐obese | 4 | 4 | |||
a
ORs and P‐values on T2DM for obese/overweight and non‐obese subjects were adjusted for age. The P‐values with statistical significance are indicated in bold numbers.